IGM scraps oncology work to focus on autoimmune, loses three executives
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Dive Brief: GE Healthcare said Friday it is investing $138 million to expand a contrast media fill and finish manufacturing site in Ireland. The company
The FDA on Friday approved a label update on Biktarvy, Gilead’s blockbuster HIV drug, to include more data on the drug’s safety and efficacy for